Oxaliplatin-induced immune thrombocytopenia in a patient with pancreatic cancer
Oxaliplatin-induced immune thrombocytopenia is a rare but potentially life-threatening side effect of chemotherapy.Management of drug-induced immune thrombocytopenia involves discontinuation of the offending drug and the use of steroids.Monitoring and follow-up are crucial in patients receiving oxaliplatin-based chemotherapy to promptly detect and manage potential hematologic emergencies, including immune thrombocytopenia.
Authors
- Mustafa Şentürk (ORCID: https://orcid.org/0000-0002-3230-1743)
- Özden Altundağ (ORCID: https://orcid.org/0000-0003-0197-6622)
Institutions
- Başkent University (TR)
Publication Details
- Journal
- European Journal of Case Reports in Internal Medicine
- Published
- 2024-08-21
- DOI
- https://doi.org/10.12890/2024_004782
- Citations
- 1
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.45